Cheng Y Liu

US Patent:

7239488, Jul 3, 2007

Filed:

Mar 9, 2004

Appl. No.:

10/797653

Inventors:

Li-Yan Zhu - San Jose CA, US
Kazumasa Yasuda - Sunnyvale CA, US
Cheng Yih Liu - San Jose CA, US
Winston Jose - San Jose CA, US

Assignee:

SAE Magnetics (H.K.), Ltd. - Shatin, N.T.

International Classification:

G11B 5/127
G11B 21/21
G11B 5/39

US Classification:

360323, 3602353, 2960314

Abstract:

According to an embodiment of the present invention, a slider design is presented that provides improved protection for the head/sensor of the slider. In one embodiment, the design of the slider is such that ESD protection is provided during the slider wafer process, the “back-end” processes (e. g. , when the completed slider/head is incorporated into an HGA), and during operation in a disk drive or the like. In this embodiment, a conductive film is provided that surrounds the insulating-material slider substrate. The conductive film provides a grounding path during the wafer fabrication processes. This conductive layer may be further patterned during head fabrication to provide a ground path for back-end fabrication processes. A conductive stripe may be added for discharging debris in the slider-to-disk interface.

US Patent:

8295882, Oct 23, 2012

Filed:

Oct 18, 2010

Appl. No.:

12/906277

Inventors:

James Fan - San Ramon CA, US
Richard Kuo - Mountain View CA, US
Cheng P. Liu - Duluth GA, US

Assignee:

AT&T Intellectual Property I, LP - Atlanta GA

International Classification:

H04B 1/38

US Classification:

455558, 455415, 455418, 4554351

Abstract:

Systems, methods, and computer program products are for managing access to a femtocell coverage area. An exemplary method includes storing in a memory component a first identifier corresponding to a subscribed service of a communication device and a second identifier corresponding to a user of the communication device, and granting access to the femtocell coverage area using the second identifier.

US Patent:

8526913, Sep 3, 2013

Filed:

Oct 8, 2012

Appl. No.:

13/647019

Inventors:

Richard Kuo - Mountain View CA, US
Cheng P Liu - Duluth GA, US

Assignee:

AT&T Intellectual Property I, L.P. - Atlanta GA

International Classification:

H04M 1/66

US Classification:

455410, 455411, 4554351

Abstract:

Systems, methods, and computer program products are for managing access to a femtocell coverage area. An exemplary method includes storing in a memory component a first identifier corresponding to a subscribed service of a communication device and a second identifier corresponding to a user of the communication device, and granting access to the femtocell coverage area using the second identifier.

US Patent:

20090155821, Jun 18, 2009

Filed:

Jan 4, 2007

Appl. No.:

12/159827

Inventors:

John Kunich - San Leandro CA, US
Cheng Liu - Richmond CA, US

International Classification:

G01N 33/574
G01N 33/566

US Classification:

435 723, 435 72

Abstract:

Methods for detecting antibody dependent cellular cytotoxicity (ADCC) are described herein. The methods are label-free, and can be performed in real time on adherent cells. The methods can include, for example, (a) monitoring the impedance between electrodes on a non-conducting substrate that supports the growth of target cells in an assay medium; and (b) adding effector cells and an antibody that binds to the target cells to the assay medium; wherein any decrease in the impedance between the electrodes on the substrate following addition of the effector cells and the antibody is indicative of ADCC function having been effected in the assay medium.

US Patent:

20090246208, Oct 1, 2009

Filed:

Jan 4, 2007

Appl. No.:

12/159665

Inventors:

Michael Kavanaugh - Orinda CA, US
Cheng Liu - Richmond CA, US

Assignee:

Novartis AG - Basel
Xoma Technology Ltd. - Hamilton

International Classification:

A61K 39/395
A61P 19/00

US Classification:

4241581

Abstract:

Methods for preventing and treating osteolysis, cancer metastasis and bone loss associated with cancer metastasis by administering an M-CSF-antagonist in combination with a therapeutic agent to a subject are provided.

US Patent:

20090265142, Oct 22, 2009

Filed:

Apr 17, 2009

Appl. No.:

12/426092

Inventors:

Cheng Liu - Fremont CA, US
Gayle L. Noble - Boulder Creek CA, US
Lucy G. Hosking - Santa Cruz CA, US
Luke M. Ekkizogloy - San Jose CA, US

Assignee:

FINISAR CORPORATION - Sunnyvale CA

International Classification:

G06F 15/00

US Classification:

702190

Abstract:

One example embodiment includes a testing device. The testing device comprises a signal reception element, an out-of-band detector and testing logic. The signal reception element is configured to receive a physical layer signal from a communication module via a physical link and to produce an incoming double modulated signal, the incoming double modulated signal including a high-speed data signal and an out-of-band data signal. The out-of-band data signal comprises diagnostic data of the communication module. The out-of-band detector is coupled to the signal reception element and is configured to extract the out-of-band data signal from the incoming double modulated signal. The testing logic is coupled to the out-of-band detector and is configured to extract and analyze the diagnostic data from the out-of-band data signal.

US Patent:

20090324604, Dec 31, 2009

Filed:

Jan 6, 2005

Appl. No.:

10/585459

Inventors:

Cheng Liu - Emeryville CA, US
Deborah Lee Zimmerman - Emeryville CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - Emeryville CA, US
William M. Kavanaugh - Emeryville CA, US
Li Long - Lafayette CA, US
Arnold Horwitz - San Leandro CA, US

Assignee:

CHIRON CORPORATION - Emeryville CA
XOMA Technology Ltd. - Hamilton

International Classification:

A61K 39/395
C07K 16/00
A61P 35/00
A61P 19/00

US Classification:

4241451, 5303873, 53038815, 53038823

Abstract:

M-CSF-specific antibody RX1 is provided, along with pharmaceutical compositions containing antibody RX1, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.

US Patent:

20110091451, Apr 21, 2011

Filed:

Aug 9, 2004

Appl. No.:

10/914598

Inventors:

William M. Kavanaugh - Orinda CA, US
Gregory M. Harrowe - Eugene OR, US
Kirston Koths - El Cerrito CA, US
Cheng Liu - Richmond CA, US
Deborah L. Zimmerman - Oakland CA, US

International Classification:

A61K 39/395
A61P 35/00
A61P 19/08

US Classification:

4241331

Abstract:

M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.